A detailed history of Fifth Third Bancorp transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 205 shares of VKTX stock, worth $14,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
205
Previous 200 2.5%
Holding current value
$14,114
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$49.84 - $70.47 $249 - $352
5 Added 2.5%
205 $12,000
Q2 2024

Jul 22, 2024

BUY
$47.39 - $80.2 $9,478 - $16,040
200 New
200 $10,000
Q2 2023

Jul 25, 2023

BUY
$14.84 - $24.79 $2,968 - $4,958
200 New
200 $3,000
Q3 2018

Nov 14, 2018

SELL
$9.7 - $19.65 $50,924 - $103,162
-5,250 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$1.74 - $4.34 $9,135 - $22,785
5,250
5,250 $21,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.28B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.